ModivCare Inc

ModivCare — Q4 2024 Earnings Presentation

24 slides from ModivCare's earnings presentation, Mar 6, 2025

  1. Slide 1: Investor Presentation 4Q 2024

    Investor Presentation 4Q 2024 © 2025 Modivcare® Inc. © 2025 Modivcare® Inc. 1

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain statements contained in herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “sh

  3. Slide 3: National Tech-Enabled Platform with Market-Leading Solutions

    National Tech-Enabled Platform with Market-Leading Solutions Supportive Care Revenue Adj. EBITDA Addressing the Social Determinants of Health (SDoH) $2.8B (1) $161M (1) Remote Transportation Personal Care Monitoring Removing barriers to In-home assistance with Connective engagement accessing care ac

  4. Slide 4: Segment Overview

    Segment Overview Non-Emergency Medical Transportation Personal Care Services Monitoring (NEMT) (PCS)  Non-medical home care for elderly and  Provides end-users of healthcare services  Health monitoring equipment and services for Business Description access to care disabled individuals in need of

  5. Slide 5: Consolidated Financial Updates

    Consolidated Financial Updates

  6. Slide 6: Consolidated Financial Highlights

    Consolidated Financial Highlights ($ in millions, except per share) 4Q 2023 4Q 2024 FY 2023 FY 2024 4Q YoY FY YoY Commentary Modivcare Consolidated  Consolidated service revenue increased 1% YoY driven primarily by: Service Revenue $702.8 $702.8 $2,751.2 $2,787.6 (0.0%) 1.3% Adjusted EBITDA $50.5 $

  7. Slide 7: FY 2024 Consolidated Adj. EBITDA Drivers

    FY 2024 | Consolidated Adj. EBITDA Drivers ($ in millions) $204 $35 $161 ($28) ($15) ($10) ($2) ($8) ($16) FY23 Redetermination Contract / Business Net Cost Savings PCS Monitoring Innovation / FY24 Adj. EBITDA Utilization Mix Development G&A Adj. EBITDA Commentary  NEMT - ($19 million) Adj. EBITDA

  8. Slide 8: 4Q 2024 Consolidated Adj. EBITDA Drivers

    4Q 2024 | Consolidated Adj. EBITDA Drivers ($ in millions) $43 $2 $2 $40 $1 ($0.4) ($1) ($6) 3Q24 Contract / Business Development Net Cost Savings PCS Monitoring Innovation / 4Q24 Adj. EBITDA Utilization Mix G&A Adj. EBITDA Commentary  4Q Adjusted EBITDA of $40 million, down $3 million from the thi

  9. Slide 9: FY 2024 Cash Position

    FY 2024 | Cash Position ($ in millions) $161 $155 $113 $2 ($69) ($26) ($9) $3 ($77) ($28) 1Q24 Adj. EBITDA Contract Core NWC / Other Debt Refinancing Cash Taxes Cash Interest Capex Draw on Revolver 4Q24 Beginning Cash AR / AP Ending Cash Commentary  Draw of $155 million on $325 million revolving cr

  10. Slide 10: Segment Financial Updates

    Segment Financial Updates | | [| modivcare

  11. Slide 11: NEMT Financial Highlights

    NEMT | Financial Highlights ($ in millions, except operating metrics) 4Q 2023 4Q 2024 FY 2023 FY 2024 4Q YoY FY YoY Commentary Service Revenue $499.1 $495.0 $1,951.4 $1,957.3 (0.8%) 0.3%  NEMT service revenue flat YoY driven by: Service Expense, Purchased Services 371.6 385.7 1456.8 1505.0 3.8% 3.3

  12. Slide 12: PCS Financial Highlights

    PCS | Financial Highlights ($ in millions, except operating metrics) 4Q 2023 4Q 2024 FY 2023 FY 2024 4Q YoY FY YoY Commentary Service Revenue, net $181.2 $186.6 (1) $715.6 $745.3 3.0% 4.1%  PCS service revenue increased YoY driven by: Service Expense $144.3 $148.2 $561.9 $599.3 2.7% 6.6% ‒ 1% organ

  13. Slide 13: Monitoring Financial Highlights

    Monitoring | Financial Highlights ($ in millions, except operating metrics) 4Q 2023 4Q 2024 FY 2023 FY 2024 4Q YoY FY YoY Commentary Service Revenue, net $20.2 $19.2 $77.9 $77.7 (5.3%) (0.3%)  Monitoring service revenue flat YoY driven by: Service Expense $6.9 $7.7 $27.0 $32.3 12.1% 19.5% ‒ ~2% mem

  14. Slide 14: Appendix

    Appendix

  15. Slide 15: NEMT Contract Receivables and Payables Summary

    NEMT | Contract Receivables and Payables Summary $166 $144 $154 $129  Contract Receivables primarily represent underpayments $120 $110 $118 and receivables on certain contracts with reconciliation $102 and risk corridor provisions. Contract $60 $72 $46  Decrease in second half of the year due to c

  16. Slide 16: NEMT Contract Mix

    NEMT | Contract Mix Structure Performance Revenue Mix (1) Shared Risk Full Risk FFS Revenue PMPM Purchased Services Fee-For-Service Margin % 85%  Fee for each service performed, often a premium excess of unit $4.82 82% cost and performance incentives $3.95 19.6% 20.3%  Revenue model: Transportatio

  17. Slide 17: Supplemental Data

    Supplemental Data | | [| modivcare

  18. Slide 18: NEMT Key Statistical and Financial Data

    NEMT | Key Statistical and Financial Data Quarterly Results - 2022 Year ended Quarterly Results - 2023 Year ended Quarterly Results - 2024 Year ended NEMT Segment Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Q4 2023 Q1 Q2 Q3 Q4 2024 Service revenue, net 400,920 448,733 459,796 458,993 1,768,442 469,463 496,975 485,951

  19. Slide 19: PCS Key Statistical and Financial Data

    PCS | Key Statistical and Financial Data Quarterly Results - 2022 Year ended Quarterly Results - 2023 Year ended Quarterly Results - 2024 Year ended PCS Segment Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Q4 2023 Q1 Q2 Q3 Q4 2024 Service revenue, net 159,698 162,737 169,226 176,013 667,674 174,131 180,325 179,979 181

  20. Slide 20: Monitoring Key Statistical and Financial Data

    Monitoring | Key Statistical and Financial Data Quarterly Results - 2022 Year ended Quarterly Results - 2023 Year ended Quarterly Results - 2024 Year ended Monitoring Segment Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Q4 2023 Q1 Q2 Q3 Q4 2024 Service revenue, net 13,857 16,745 18,760 18,915 68,277 18,712 19,211 19,7

  21. Slide 21: Corporate and Other Key Statistical and Financial Data

    Corporate and Other | Key Statistical and Financial Data Quarterly Results - 2022 Year ended Quarterly Results - 2023 Year ended Quarterly Results - 2024 Year ended Corporate and Other Segment Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Q4 2023 Q1 Q2 Q3 Q4 2024 G&A expense 11,380 15,735 16,201 17,399 60,715 17,406 25

  22. Slide 22: Non-GAAP Reconciliations

    Non-GAAP Reconciliations | | [| modivcare

  23. Slide 23: Non-GAAP Reconciliation

    Non-GAAP Reconciliation (dollars in thousands) FY2022 1Q23 2Q23 3Q23 4Q23 FY 2023 1Q24 2Q24 3Q24 4Q24 FY 2024 Net income (loss) ($31,806) ($3,962) ($190,944) ($4,302) ($5,252) ($204,460) ($22,300) ($128,884) ($26,604) ($23,490) ($201,278) Provision (benefit) for income taxes (3,035) (1,873) (830) (1

  24. Slide 24: Non-GAAP Reconciliation Segments

    Non-GAAP Reconciliation | Segments NEMT Segment PCS Segment Monitoring Segment Reconciliation of Non-GAAP Financial Measures Reconciliation of Non-GAAP Financial Measures Reconciliation of Non-GAAP Financial Measures Twelve Months Twelve Months Twelve Months Ended Dec 31, Ended Dec 31, Ended Dec 31,

ModivCare — Q4 2024 Earnings Presentation on 6ix